Floatz logo

MIVACURIUM ION

Parkinson's Disease

Columbia UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

52 Active assets in the Parkinson's Disease cohort.

Asset / SponsorPhaseRating
Tvp-1012
Guangzhou Henovcom Bioscience Co. Ltd.
Phase 4BBB
Istradefylline
Georgetown University
Phase 4BBB
LEVODOPA
Ihab Elsayed Hassan
Phase 4BBB
carbidopa
Tanta University
Phase 4BBB
Entacapone
University Hospital Tuebingen
Phase 4BBB

View all 50 →

Same molecule, other indications

MIVACURIUM ION is also rated in:

Anesthesia, IntravenousDormant
BBB
Indicative ·
73 / 100
View asset →
RemifentanilDormant
BB
Indicative ·
69 / 100
View asset →
SternotomyDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →